Brian E. Weinrich

Array ( [id] => 2754178 [patent_doc_number] => 05071959 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1991-12-10 [patent_title] => 'Novel lymphokine for suppressing platelet activation' [patent_app_type] => 1 [patent_app_number] => 7/168009 [patent_app_country] => US [patent_app_date] => 1988-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 8 [patent_no_of_words] => 4190 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/071/05071959.pdf [firstpage_image] =>[orig_patent_app_number] => 168009 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2891071 [patent_doc_number] => 05239060 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-08-24 [patent_title] => 'Muscular dystrophy protein, dystrophin' [patent_app_type] => 1 [patent_app_number] => 7/136618 [patent_app_country] => US [patent_app_date] => 1987-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 9995 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/239/05239060.pdf [firstpage_image] =>[orig_patent_app_number] => 136618 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2939035 [patent_doc_number] => 05260421 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-11-09 [patent_title] => 'Site-directed mutagenesis modified glycoprotein hormones' [patent_app_type] => 1 [patent_app_number] => 7/136236 [patent_app_country] => US [patent_app_date] => 1987-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4504 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/260/05260421.pdf [firstpage_image] =>[orig_patent_app_number] => 136236 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2697707 [patent_doc_number] => 04988622 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1991-01-29 [patent_title] => 'Recombinant plasmid DNA pVN 22 coding biosynthesis of human leukocyte interferon alpha-I1 and strain Pseudomonas sp. 31 (pVN 22) - producer of human leukocyte interferon alpha-I1 containing same' [patent_app_type] => 1 [patent_app_number] => 7/163967 [patent_app_country] => US [patent_app_date] => 1987-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5169 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 206 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/988/04988622.pdf [firstpage_image] =>[orig_patent_app_number] => 163967 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2894080 [patent_doc_number] => 05183746 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-02-02 [patent_title] => 'Formulation processes for pharmaceutical compositions of recombinant .beta. -' [patent_app_type] => 1 [patent_app_number] => 7/100679 [patent_app_country] => US [patent_app_date] => 1987-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 20837 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 172 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/183/05183746.pdf [firstpage_image] =>[orig_patent_app_number] => 100679 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3089855 [patent_doc_number] => 05278286 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-01-11 [patent_title] => 'Immune interferon' [patent_app_type] => 1 [patent_app_number] => 7/016610 [patent_app_country] => US [patent_app_date] => 1987-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 4 [patent_no_of_words] => 7599 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/278/05278286.pdf [firstpage_image] =>[orig_patent_app_number] => 016610 [rel_patent_id] =>[rel_patent_doc_number] =>)